[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[S. 2020 Introduced in Senate (IS)]

<DOC>






116th CONGRESS
  1st Session
                                S. 2020

 To amend title XVIII of the Social Security Act to expand the use of 
    telehealth services for remote imaging for chronic eye disease.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                             June 27, 2019

Mr. Casey (for himself and Mr. Grassley) introduced the following bill; 
     which was read twice and referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL


 
 To amend title XVIII of the Social Security Act to expand the use of 
    telehealth services for remote imaging for chronic eye disease.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Screenings for Eye Evaluation, 
Monitoring, Observation, Review, and Examination Act'' or the ``SEE 
MORE Act''.

SEC. 2. EXPANDING THE USE OF TELEHEALTH SERVICES FOR REMOTE IMAGING FOR 
              CHRONIC EYE DISEASE.

    Section 1834(m) of the Social Security Act (42 U.S.C. 1395m(m)) is 
amended--
            (1) in paragraph (4)(C)(i), by striking ``and (7)'' and 
        inserting ``(7), and (8)''; and
            (2) by adding at the end the following new paragraph:
            ``(8) Treatment of remote imaging for chronic eye 
        disease.--
                    ``(A) Non-application of originating site 
                requirements.--The requirements described in paragraph 
                (4)(C) shall not apply with respect to telehealth 
                services furnished on or after January 1, 2020, for 
                purposes of providing remote imaging for chronic eye 
                disease, as determined by the Secretary, including 
                diabetic eye disease and glaucoma. Such screenings and 
                services shall include the use of FDA-approved ocular 
                imaging techniques and technologies, including 
                artificial intelligence technologies, shown to support 
                the accurate diagnosis or monitoring or treatment of 
                diabetic retinopathy, glaucoma, or other chronic eye 
                disease, as determined by the Secretary.
                    ``(B) No originating site facility fee for new 
                sites.--No facility fee shall be paid under paragraph 
                (2)(B) to an originating site with respect to a 
                telehealth service described in subparagraph (A) if the 
                originating site does not otherwise meet the 
                requirements for an originating site under paragraph 
                (4)(C).
                    ``(C) Report.--Not later than 5 years after the 
                date of the enactment of this paragraph, the Secretary 
                shall submit to Congress a report on the impact of this 
                paragraph with respect to telehealth services on--
                            ``(i) the utilization of health care items 
                        and services related to diabetes and glaucoma;
                            ``(ii) health outcomes related to diabetes 
                        and glaucoma; and
                            ``(iii) the rates of specialty referrals 
                        and the rate for completion of a specialty 
                        visit within 90 days of referral for 
                        individuals with diabetic retinopathy or 
                        glaucoma after receiving telehealth 
                        services.''.
                                 <all>